A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial Evaluating the Effect of Intranasal Insulin on Cognition and Emotional Processing in Individuals with Treatment-Resistant Major Depressive Disorder
Year: 2016
Type: dissertation
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Aim: Available evidence indicates that individuals with major depressive disorder (MDD) differentially respond to emotionally valenced information alongside impairments in cognition; however, the exact underlying pathophysiological mechanisms subserving these deficits have yet to be elucidated. This thesis represents a proof-of-concept study informed by extant evidence implicating altered brain metabolism and function in individuals with MDD. Methods: Subjects (N=35) were randomized to receive 40 IU QID placebo (n=16) or insulin (n=19) in this double-blind, placebo-controlled, crossover study to examine the effects of intranasal insulin on measures evaluating mood, neurocognition, and quality of life. Results: No significant differences were observed on any primary measures of interest following analyses. However, methodological limitations (i.e., significant carryover/practice effects) should be taken into consideration for interpretation. Conclusion: Intranasal insulin did not demonstrate an effect on mood, neurocognitive/ neuropsychological, or quality of life metrics. Approaches for future trials with intranasal insulin in this clinical population are discussed.
Source: TSpace (University of Toronto)
Author: Cha, Danielle Soh-Young
Institution: University of Toronto
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6986766811
